Register for news & events
April 24
Improving Vision in Congenital Nystagmus – Pivotal RCT Results – AAPOS 2024
During the scientific program at AAPOS 2024 in Boston, Dr. Idan Hecht presented the groundbreaking findings from a prospective randomized controlled trial evaluating the efficacy of RevitalVision in improving vision in Congenital Nystagmus patients. the study demonstrated statistically significant improvement in distance and near BCVA, and significant improvement in stereo and binocular functions, offering new hope for nystagmus patients, lacking alternative solutions to improve vision.
Watch presentation
Contact Us
Talshir Medical Technologies LTD
USA Office: 1.800.361.8218 | Main Office: +972.77.212.3272
